TY - JOUR
T1 - Host–microbe interactions
T2 - communication in the microbiota–gut–brain axis
AU - Shekarabi, Aryan
AU - Qureishy, Izhan
AU - Puglisi, Chloe H.
AU - Dalseth, Marge
AU - Vuong, Helen E.
N1 - Publisher Copyright:
© 2024 Elsevier Ltd
PY - 2024/8
Y1 - 2024/8
N2 - Animals harbor a diverse array of symbiotic micro-organisms that coexist in communities across different body sites. These microbes maintain host homeostasis and respond to environmental insults to impact host physiological processes. Trillions of indigenous microbes reside in the gastrointestinal tract and engage with the host central nervous system (microbiota–gut–brain axis) by modulating immune responses, interacting with gut intrinsic and extrinsic nervous system, and regulating neuromodulators and biochemicals. These gut microbiota to brain signaling pathways are constantly informed by each other and are hypothesized to mediate brain health across the lifespan. In this review, we will examine the crosstalk of gut microbiota to brain communications in neurological pathologies, with an emphasis on microbial metabolites and neuromodulators, and provide a discussion of recent advances that help elucidate the microbiota as a therapeutic target for treating brain and behavioral disorders.
AB - Animals harbor a diverse array of symbiotic micro-organisms that coexist in communities across different body sites. These microbes maintain host homeostasis and respond to environmental insults to impact host physiological processes. Trillions of indigenous microbes reside in the gastrointestinal tract and engage with the host central nervous system (microbiota–gut–brain axis) by modulating immune responses, interacting with gut intrinsic and extrinsic nervous system, and regulating neuromodulators and biochemicals. These gut microbiota to brain signaling pathways are constantly informed by each other and are hypothesized to mediate brain health across the lifespan. In this review, we will examine the crosstalk of gut microbiota to brain communications in neurological pathologies, with an emphasis on microbial metabolites and neuromodulators, and provide a discussion of recent advances that help elucidate the microbiota as a therapeutic target for treating brain and behavioral disorders.
UR - http://www.scopus.com/inward/record.url?scp=85194563954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85194563954&partnerID=8YFLogxK
U2 - 10.1016/j.mib.2024.102494
DO - 10.1016/j.mib.2024.102494
M3 - Review article
C2 - 38824840
AN - SCOPUS:85194563954
SN - 1369-5274
VL - 80
JO - Current Opinion in Microbiology
JF - Current Opinion in Microbiology
M1 - 102494
ER -